Quality of life in women with recurrent breast cancer.

PubWeight™: 0.92‹?›

🔗 View Article (PMID 10369080)

Published in Breast Cancer Res Treat on March 01, 1999

Authors

A A Bull1, B E Meyerowitz, S Hart, P Mosconi, G Apolone, A Liberati

Author Affiliations

1: Department of Psychology, University of Southern California, Los Angeles 90089-1061, USA.

Articles by these authors

Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 10.03

Practice guidelines developed by specialty societies: the need for a critical appraisal. Lancet (2000) 8.10

Translating health status questionnaires and evaluating their quality: the IQOLA Project approach. International Quality of Life Assessment. J Clin Epidemiol (1998) 5.15

Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol (2000) 4.96

Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol (2008) 4.70

Surgical audit: Comparison of the work load and results of two hospitals in the same district. Br Med J (1980) 4.54

Life after breast cancer: understanding women's health-related quality of life and sexual functioning. J Clin Oncol (1998) 4.35

Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women. J Clin Oncol (1998) 3.65

The Italian SF-36 Health Survey: translation, validation and norming. J Clin Epidemiol (1998) 3.55

The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 3.40

Consumer participation in research and health care. BMJ (1997) 3.38

What contributions do languages other than English make on the results of meta-analyses? J Clin Epidemiol (2000) 3.37

The factor structure of the SF-36 Health Survey in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 3.37

The importance of co-existent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement. Comorbidity and outcomes after hip replacement. Med Care (1993) 3.19

Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews. Lancet (1996) 3.17

A quality assessment of randomized control trials of primary treatment of breast cancer. J Clin Oncol (1986) 3.14

Stopping a trial early in oncology: for patients or for industry? Ann Oncol (2008) 3.06

Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J Biol Chem (1992) 2.97

The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification. Endocr Relat Cancer (2001) 2.76

Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology (2001) 2.74

Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors. N Engl J Med (1992) 2.73

Role of breast reconstructive surgery in physical and emotional outcomes among breast cancer survivors. J Natl Cancer Inst (2000) 2.66

International Quality of Life Assessment (IQOLA) Project. Qual Life Res (1992) 2.64

Benefits and costs of screening and treatment for early breast cancer. Development of a basic benefit package. JAMA (1995) 2.62

ASA Physical Status and age predict morbidity after three surgical procedures. Ann Surg (1994) 2.52

Randomized clinical trials on medical treatment of glaucoma. Are they appropriate to guide clinical practice? Arch Ophthalmol (1993) 2.44

EGFR signal transactivation in cancer cells. Biochem Soc Trans (2003) 2.42

The effect of message framing on breast self-examination attitudes, intentions, and behavior. J Pers Soc Psychol (1987) 2.26

Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 2.22

Quality, evolution, and clinical implications of randomized, controlled trials on the treatment of lung cancer. A lost opportunity for meta-analysis. JAMA (1989) 2.18

Quality of systematic reviews used in guidelines for oncology practice. Ann Oncol (2006) 2.15

Patterns of cigarette smoking and alcohol use among lesbians and bisexual women enrolled in a large health maintenance organization. Am J Public Health (2001) 2.06

Cross-cultural comparisons of the content of SF-36 translations across 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 2.05

Follow-up strategies for women treated for early breast cancer. Cochrane Database Syst Rev (2005) 1.98

Disclosure of breast cancer diagnosis: patient and physician reports. GIVIO (Interdisciplinary Group for Cancer Care Evaluation, Italy) Ann Oncol (1991) 1.87

Testing the equivalence of translations of widely used response choice labels: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 1.86

Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials. Ann Oncol (1997) 1.85

Use of structural equation modeling to test the construct validity of the SF-36 Health Survey in ten countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 1.79

Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials. BMJ (1998) 1.75

A European version of the Appropriateness Evaluation Protocol. Goals and presentation. The BIOMED I Group on Appropriateness of Hospital Use. Int J Technol Assess Health Care (1999) 1.73

Comparison of Rasch and summated rating scales constructed from SF-36 physical functioning items in seven countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 1.69

Predictors of sexual health in women after a breast cancer diagnosis. J Clin Oncol (1999) 1.67

The impact of patient management guidelines on the care of breast, colorectal, and ovarian cancer patients in Italy. Med Care (1991) 1.62

Does a drug do better when it is new? Ann Oncol (2002) 1.61

Reliability study of the European appropriateness evaluation protocol. Int J Qual Health Care (1999) 1.59

Health-related quality of life in dialysis patients. A report from an Italian study using the SF-36 Health Survey. DIA-QOL Group. Nephrol Dial Transplant (1999) 1.57

Outcome for infants at high risk of major handicap. Ciba Found Symp (1978) 1.52

Incessant ovulation and ovarian cancer: a critical approach. Int J Epidemiol (1983) 1.51

Pediatric risk of mortality: an assessment of its performance in a sample of 26 Italian intensive care units. Crit Care Med (1998) 1.50

Essential requirements for practice guidelines at national and local levels. Neurol Sci (2004) 1.49

A meta-analysis of trials on aldose reductase inhibitors in diabetic peripheral neuropathy. The Italian Study Group. The St. Vincent Declaration. Diabet Med (1996) 1.46

Adjuvant portal-vein infusion of fluorouracil and heparin in colorectal cancer: a randomised trial. European Organisation for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group, the Gruppo Interdisciplinare Valutazione Interventi in Oncologia, and the Japanese Foundation for Cancer Research. Lancet (1998) 1.46

Prevention of pneumonia in an intensive care unit: a randomized multicenter clinical trial. Intensive Care Unit Group of Infection Control. Crit Care Med (1989) 1.45

The risk of bias from omitted research. BMJ (2000) 1.43

Do specialists do it better? The impact of specialization on the processes and outcomes of care for cancer patients. Ann Oncol (1998) 1.43

The use of the laryngeal mask airway to facilitate the insertion of a percutaneous tracheostomy. Intensive Care Med (1994) 1.42

The consequences of under-use of coronary revascularization; results of a cohort study in Northern Italy. Eur Heart J (2001) 1.41

The impact of cancer treatment guidelines on actual practice in Italian general hospitals: the case of ovarian cancer. Ann Oncol (1990) 1.40

Early experience with needle localization and biopsy of mammographic lesions. Aust N Z J Surg (1990) 1.40

Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding. Obstet Gynecol (1997) 1.38

The Migraine Disability Assessment (MIDAS) questionnaire: translation and reliability of the Italian version. Cephalalgia (2001) 1.38

Quality of life after radical cystectomy for bladder cancer in patients with an ileal conduit, cutaneous or urethral kock pouch. J Urol (1999) 1.36

Impact of different adjuvant therapy strategies on quality of life in breast cancer survivors. Recent Results Cancer Res (1998) 1.35

Effects of new smoking regulations in Italy. Ann Oncol (2005) 1.32

Impact of different customization strategies in the performance of a general severity score. Crit Care Med (1997) 1.30

One model, several results: the paradox of the Hosmer-Lemeshow goodness-of-fit test for the logistic regression model. J Epidemiol Biostat (2000) 1.26

Long-term respiratory support and risk of pneumonia in critically ill patients. Intensive Care Unit Group of Infection Control. Am Rev Respir Dis (1989) 1.26

Promoting consumers' demand for evidence-based medicine. Int J Technol Assess Health Care (1998) 1.24

Quality of life research in oncology. Past achievements and future priorities. Cancer (1991) 1.23

Practice guidelines: useful and "participative" method? Survey of Italian physicians by professional setting. Arch Intern Med (2001) 1.22

Missing quality of life data in cancer clinical trials: serious problems and challenges. Stat Med (1998) 1.22

Validation of Italian multiple sclerosis quality of life 54 questionnaire. J Neurol Neurosurg Psychiatry (1999) 1.21

Early onset pneumonia: a multicenter study in intensive care units. Intensive Care Med (1987) 1.20

Positive expectations predict health after heart transplantation. Health Psychol (1995) 1.18

Adjuvant chemotherapy for breast carcinoma: psychosocial implications. Cancer (1979) 1.17

Psychosocial correlates of breast cancer and its treatments. Psychol Bull (1980) 1.17

Subjective health status assessment: evaluation of the Italian version of the SF-12 Health Survey. Results from the MiOS Project. J Epidemiol Biostat (2001) 1.15

Follow-up strategies for women treated for early breast cancer. Cochrane Database Syst Rev (2000) 1.13

Evaluation of the uniformity of fit of general outcome prediction models. Intensive Care Med (1998) 1.10

Evaluation of the EORTC QLQ-C30 questionnaire: a comparison with SF-36 Health Survey in a cohort of Italian long-survival cancer patients. Ann Oncol (1998) 1.10

Updating clinical recommendations for breast, colorectal and lung cancer treatments: an opportunity to improve methodology and clinical relevance. Ann Oncol (2010) 1.09

Autoantibody activity of immunoglobulins isolated from B-cell follicular lymphomas. Blood (1991) 1.09

Metabolic syndrome, psychological status and quality of life in obesity: the QUOVADIS Study. Int J Obes (Lond) (2007) 1.09

The role of attitudes, beliefs, and personal characteristics of Italian physicians in the surgical treatment of early breast cancer. Am J Public Health (1991) 1.07

In-vitro activity of S. lavandulaefolia (Spanish sage) relevant to treatment of Alzheimer's disease. J Pharm Pharmacol (2001) 1.07

Association of systemic immune complexes, complement activation, and antibodies to Pseudomonas aeruginosa lipopolysaccharide and exotoxin A with mortality in cystic fibrosis. Am Rev Respir Dis (1986) 1.06

Band 3 mutations, renal tubular acidosis and South-East Asian ovalocytosis in Malaysia and Papua New Guinea: loss of up to 95% band 3 transport in red cells. Biochem J (2000) 1.05

Studies on the mode of action of the essential oil of lavender (Lavandula angustifolia P. Miller). Phytother Res (1999) 1.04

Childhood sexual abuse, psychological distress, and medical use among women. Psychosom Med (2000) 1.04

Epithelial cysts of the spleen. Br J Surg (1970) 1.04

Alcohol risk assessment and intervention for family physicians. Project of the College of Family Physicians of Canada. Can Fam Physician (1996) 1.04

Appropriateness of hospital use: an overview of Italian studies. Int J Qual Health Care (1995) 1.03

TG02, a novel oral multi-kinase inhibitor of CDKs, JAK2 and FLT3 with potent anti-leukemic properties. Leukemia (2011) 1.02